JPRN-jRCT2031210530招募中1 期
ONO-7914-01:A Phase I, open-label, uncontrolled, dose escalation study to evaluate the tolerability and safety of ONO-7914 alone and in combination with ONO-4538 in patients with advanced or metastatic solid tumors
Hirashima Yoshinori0 个研究点目标入组 204 人开始时间: 2021年12月28日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 204
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •1.Patients with advanced or metastatic solid tumor
- •2.Patients with ECOG performance status of 0 or 1
- •3.Patients with a life expectancy of at least 3 months
排除标准
- •1.Patients with severe complication
- •2.Patients judged to be incapable of providing consent for reasons such as concurrent dementia
研究者
相似试验
进行中（未招募）
1 期
ONO-7119-01:Phase I study of ONO-7119 alone and in combination with ONO-4538 in patients with solid tumorsJPRN-jRCT2031210373Hirashima Yoshinori74
进行中（未招募）
1 期
ONO-7913-04: ONO-7913 Phase 1 StudyJPRN-jRCT2051210038Hirashima Yoshinori60
进行中（未招募）
1 期
ONO-7475-03 : ONO-7475 Phase 1 StudyEGFR mutated, stage IIIB/IIIC/IV or recurrent, NSCLC, which is unsuitable for radical irradiationJPRN-jRCT2051210045Osawa Masahiro75
进行中（未招募）
1 期
ONO-7913-02 : ONO-7913 Phase 1 StudyJPRN-jRCT2031210139Osawa Masahiro12
进行中（未招募）
1 期
ONO-4059-08:ONO-4059 phase 1Systemic SclerosisJPRN-jRCT2031200315Osawa Masahiro16